RE-BVS – Piemonte Repository

Sfoglia per AUTORE
VENDITTI A
Collezione AOU Novara

Items : 9

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy. in Haematologica / Haematologica. 2025 Mar 1;110(3):608-620. doi: 10.3324/haematol.2024.285448.

2025
AOU Città della Salute di Torino
AOU Novara

Huls G; Valent P; Eisfeld AK; Albano F; Visani G; DiBona E; Roti G; Rigolin GM; Marvalle D; Audisio E; Festuccia M; Venditti A; Forghieri F; Galimberti S; Lanza F; Pullarkat S; Lunghi M; Gotlib JR; Candoni A; Capelli D; Deeg HJ; Gurrieri C; Yeung CCS; Cairoli R; Morgan EA; Ferrara F; Marcucci G; Papayannidis C; Tecchio C; et alii...

Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. in JCO oncology practice / JCO Oncol Pract. 2024 Mar;20(3):438-447. doi: 10.1200/OP.23.00434. Epub 2024 Jan 11.

2024
AO Ordine Mauriziano
AOU Novara

Fazi P; Platzbecker U; Luppi M; Baron F; Di Maio M; Perrone F; Venditti A; Voso MT; Brini A; Cavo M; Anota A; Gaidano G; Giesinger JM; Sparano F; Vignetti M; Efficace F;

Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial. in Blood / Blood. 2024 Aug 1;144(5):541-551. doi: 10.1182/blood.2023023625.

2024
AOU Città della Salute di Torino
AOU Novara

Fazi P; Mengarelli A; Legrand O; Baron F; Candoni A; Posthuma EFM; Vrhovac R; Venditti A; Gaidano G; Crysandt M; Fuhrmann S; Foà R; Audisio E; Luppi M; Neubauer A; Griskevicius L; Chantepie S; Noppeney R; van der Velden WJFM; Coens C; Suciu S; Kicinski M; Efficace F; Vignetti M; Giraut A; Wijermans PW; Huls G; Lübbert M;

10-day decitabine versus 3?+?7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9.

2023
AOU Città della Salute di Torino
AOU Novara

Becker H; Blijlevens N; Wäsch R; Vilque JP; Ammatuna E; Efficace F; de Graaf AO; Stevens-Kroef M; Jansen JH; Hoogendoorn M; Giraut A; Posthuma EFM; van Lammeren-Venema D; Gaidano G; Foà R; Legrand O; Candoni A; Audisio E; Fuhrmann S; Luppi M; Vrhovac R; Crysandt M; Neubauer A; Griškevi?ius L; Noppeney R; Van der Velden WJFM; Chantepie S; Kicinski M; Wijermans PW; et alii...

Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy. in Leukemia research / Leuk Res. 2023 Apr;127:107040. doi: 10.1016/j.leukres.2023.107040. Epub 2023 Feb 14.

2023
AOU Novara

Maurillo L; Spagnoli A; Candoni A; Papayannidis C; Borlenghi E; Lazzarotto D; Fianchi L; Sciumè M; Zannier ME; Buccisano F; Del Principe MI; Mancini V; Breccia M; Fanin R; Todisco E; Lunghi M; Palmieri R; Fracchiolla N; Musto P; Rossi G; Venditti A;

Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group. in British journal of haematology / Br J Haematol. 2022 Nov;199(4):507-519. doi: 10.1111/bjh.18396. Epub 2022 Aug 9.

2022
AOU Novara

Steffanoni S; Calimeri T; Laurenge A; Fox CP; Soussain C; Grommes C; Tisi MC; Boot J; Crosbie N; Visco C; Arcaini L; Chaganti S; Sassone MC; Alencar A; Armiento D; Romano I; Dietrich J; Itchaki G; Bruna R; Fracchiolla NS; Arletti L; Venditti A; Booth S; Musto P; Hoang Xuan K; Batchelor TT; Cwynarski K; Ferreri AJM;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Merli F; Passamonti F; Candoni A; Krampera M; Venditti A; Selleri C; Tosi P; Lanza F; Conconi A; La Barbera EO; Gambacorti-Passerini C; Visani G; Vallisa D; Rigacci L; Armiento D; Gherlinzoni F; Tafuri A; Galimberti S; Bocchia M; Corso A; Cilloni D; Cardinali V; Turrini M; Trentin L; Cuneo A; Della Porta M; Massaia M; Fracchiolla N; et alii...

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.

2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Grossi PA; Bertù L; Zaja F; Musto P; Petrucci L; Lanza F; Visani G; Mina R; La Barbera EO; Cattaneo C; Candoni A; Krampera M; Luppi M; Cardinali V; Galimberti S; Armiento D; Bocchia M; Marchesi F; Fracchiolla N; Tafuri A; Pinto A; Arcaini L; Massaia M; Ladetto M; Busca A; Venditti A; Farina F; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Pinto A; Galieni P; Rigacci L; Candoni A; Venditti A; Fava C; Federici AB; Marchesi F; Musto P; Gentile M; Bocchia M; Di Renzo N; Olivieri A; Ferrandina C; Selleri C; Ortu La Barbera E; Luppi M; Scattolin AM; et alii...